INHIBITEURS DE TGF?1 SÉLECTIFS SELON L'ISOFORME À AFFINITÉ ÉLEVÉE

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHAPRON, Christopher, WAWERSIK, Stefan, STEIN, Caitlin, BUCKLER, Alan, COOPER, Anthony, JACKSON, Justin, W, LIN, Susan, SCHURPF, Thomas, DAGBAY, Kevin, B, CAPILI, Allan, DATTA, Abhishek, SALOTTO, Matthew, AVERY, Andrew, MARTIN, Constance, LITTLEFIELD, Christopher, CARVEN, Gregory, J
Format: Patent
Sprache:fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHAPRON, Christopher
WAWERSIK, Stefan
STEIN, Caitlin
BUCKLER, Alan
COOPER, Anthony
JACKSON, Justin, W
LIN, Susan
SCHURPF, Thomas
DAGBAY, Kevin, B
CAPILI, Allan
DATTA, Abhishek
SALOTTO, Matthew
AVERY, Andrew
MARTIN, Constance
LITTLEFIELD, Christopher
CARVEN, Gregory, J
description Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MA53125A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MA53125A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MA53125A3</originalsourceid><addsrcrecordid>eNrjZHDz9PPwdPIMcQ0NClZwcVUIcXezN1QIPtzp4-oc4ukWrBDs6uPvp-Cj7hns7-Yf5OuqcLhBwdENqM0z5HCnAkhd2OFOVx4G1rTEnOJUXijNzSDr5hri7KGbWpAfn1pckJicmpdaEu_raGpsaGTqaExIHgCeNi30</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITEURS DE TGF?1 SÉLECTIFS SELON L'ISOFORME À AFFINITÉ ÉLEVÉE</title><source>esp@cenet</source><creator>CHAPRON, Christopher ; WAWERSIK, Stefan ; STEIN, Caitlin ; BUCKLER, Alan ; COOPER, Anthony ; JACKSON, Justin, W ; LIN, Susan ; SCHURPF, Thomas ; DAGBAY, Kevin, B ; CAPILI, Allan ; DATTA, Abhishek ; SALOTTO, Matthew ; AVERY, Andrew ; MARTIN, Constance ; LITTLEFIELD, Christopher ; CARVEN, Gregory, J</creator><creatorcontrib>CHAPRON, Christopher ; WAWERSIK, Stefan ; STEIN, Caitlin ; BUCKLER, Alan ; COOPER, Anthony ; JACKSON, Justin, W ; LIN, Susan ; SCHURPF, Thomas ; DAGBAY, Kevin, B ; CAPILI, Allan ; DATTA, Abhishek ; SALOTTO, Matthew ; AVERY, Andrew ; MARTIN, Constance ; LITTLEFIELD, Christopher ; CARVEN, Gregory, J</creatorcontrib><description>Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.</description><language>fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210519&amp;DB=EPODOC&amp;CC=MA&amp;NR=53125A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210519&amp;DB=EPODOC&amp;CC=MA&amp;NR=53125A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHAPRON, Christopher</creatorcontrib><creatorcontrib>WAWERSIK, Stefan</creatorcontrib><creatorcontrib>STEIN, Caitlin</creatorcontrib><creatorcontrib>BUCKLER, Alan</creatorcontrib><creatorcontrib>COOPER, Anthony</creatorcontrib><creatorcontrib>JACKSON, Justin, W</creatorcontrib><creatorcontrib>LIN, Susan</creatorcontrib><creatorcontrib>SCHURPF, Thomas</creatorcontrib><creatorcontrib>DAGBAY, Kevin, B</creatorcontrib><creatorcontrib>CAPILI, Allan</creatorcontrib><creatorcontrib>DATTA, Abhishek</creatorcontrib><creatorcontrib>SALOTTO, Matthew</creatorcontrib><creatorcontrib>AVERY, Andrew</creatorcontrib><creatorcontrib>MARTIN, Constance</creatorcontrib><creatorcontrib>LITTLEFIELD, Christopher</creatorcontrib><creatorcontrib>CARVEN, Gregory, J</creatorcontrib><title>INHIBITEURS DE TGF?1 SÉLECTIFS SELON L'ISOFORME À AFFINITÉ ÉLEVÉE</title><description>Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDz9PPwdPIMcQ0NClZwcVUIcXezN1QIPtzp4-oc4ukWrBDs6uPvp-Cj7hns7-Yf5OuqcLhBwdENqM0z5HCnAkhd2OFOVx4G1rTEnOJUXijNzSDr5hri7KGbWpAfn1pckJicmpdaEu_raGpsaGTqaExIHgCeNi30</recordid><startdate>20210519</startdate><enddate>20210519</enddate><creator>CHAPRON, Christopher</creator><creator>WAWERSIK, Stefan</creator><creator>STEIN, Caitlin</creator><creator>BUCKLER, Alan</creator><creator>COOPER, Anthony</creator><creator>JACKSON, Justin, W</creator><creator>LIN, Susan</creator><creator>SCHURPF, Thomas</creator><creator>DAGBAY, Kevin, B</creator><creator>CAPILI, Allan</creator><creator>DATTA, Abhishek</creator><creator>SALOTTO, Matthew</creator><creator>AVERY, Andrew</creator><creator>MARTIN, Constance</creator><creator>LITTLEFIELD, Christopher</creator><creator>CARVEN, Gregory, J</creator><scope>EVB</scope></search><sort><creationdate>20210519</creationdate><title>INHIBITEURS DE TGF?1 SÉLECTIFS SELON L'ISOFORME À AFFINITÉ ÉLEVÉE</title><author>CHAPRON, Christopher ; WAWERSIK, Stefan ; STEIN, Caitlin ; BUCKLER, Alan ; COOPER, Anthony ; JACKSON, Justin, W ; LIN, Susan ; SCHURPF, Thomas ; DAGBAY, Kevin, B ; CAPILI, Allan ; DATTA, Abhishek ; SALOTTO, Matthew ; AVERY, Andrew ; MARTIN, Constance ; LITTLEFIELD, Christopher ; CARVEN, Gregory, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MA53125A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fre</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHAPRON, Christopher</creatorcontrib><creatorcontrib>WAWERSIK, Stefan</creatorcontrib><creatorcontrib>STEIN, Caitlin</creatorcontrib><creatorcontrib>BUCKLER, Alan</creatorcontrib><creatorcontrib>COOPER, Anthony</creatorcontrib><creatorcontrib>JACKSON, Justin, W</creatorcontrib><creatorcontrib>LIN, Susan</creatorcontrib><creatorcontrib>SCHURPF, Thomas</creatorcontrib><creatorcontrib>DAGBAY, Kevin, B</creatorcontrib><creatorcontrib>CAPILI, Allan</creatorcontrib><creatorcontrib>DATTA, Abhishek</creatorcontrib><creatorcontrib>SALOTTO, Matthew</creatorcontrib><creatorcontrib>AVERY, Andrew</creatorcontrib><creatorcontrib>MARTIN, Constance</creatorcontrib><creatorcontrib>LITTLEFIELD, Christopher</creatorcontrib><creatorcontrib>CARVEN, Gregory, J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHAPRON, Christopher</au><au>WAWERSIK, Stefan</au><au>STEIN, Caitlin</au><au>BUCKLER, Alan</au><au>COOPER, Anthony</au><au>JACKSON, Justin, W</au><au>LIN, Susan</au><au>SCHURPF, Thomas</au><au>DAGBAY, Kevin, B</au><au>CAPILI, Allan</au><au>DATTA, Abhishek</au><au>SALOTTO, Matthew</au><au>AVERY, Andrew</au><au>MARTIN, Constance</au><au>LITTLEFIELD, Christopher</au><au>CARVEN, Gregory, J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITEURS DE TGF?1 SÉLECTIFS SELON L'ISOFORME À AFFINITÉ ÉLEVÉE</title><date>2021-05-19</date><risdate>2021</risdate><abstract>Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fre
recordid cdi_epo_espacenet_MA53125A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title INHIBITEURS DE TGF?1 SÉLECTIFS SELON L'ISOFORME À AFFINITÉ ÉLEVÉE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T21%3A37%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHAPRON,%20Christopher&rft.date=2021-05-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMA53125A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true